171 related articles for article (PubMed ID: 7717187)
1. Platelet-vessel wall interactions, focal adhesions, and the mechanism of action of endothelial factors.
Walter U; Geiger J; Haffner C; Markert T; Nehls C; Silber RE; Schanzenbächer P
Agents Actions Suppl; 1995; 45():255-68. PubMed ID: 7717187
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-dependent phosphorylation of vasodilator-stimulated protein in platelets during coronary passage.
Pohl U; Nolte C; Bunse A; Eigenthaler M; Walter U
Am J Physiol; 1994 Feb; 266(2 Pt 2):H606-12. PubMed ID: 8141362
[TBL] [Abstract][Full Text] [Related]
3. Influence of endothelin on human platelet aggregation and prostacyclin generation from human vascular endothelial cells in culture.
Kato K; Sawada S; Toyoda T; Kobayashi K; Shirai K; Yamamoto K; Tamagaki T; Yamagami M; Yoneda M; Takada O
Jpn Circ J; 1992 May; 56(5):422-31. PubMed ID: 1318427
[TBL] [Abstract][Full Text] [Related]
4. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
Hyslop S; de Nucci G
Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
[TBL] [Abstract][Full Text] [Related]
5. [Endothelial factors and thrombocyte function].
Schrör K
Z Kardiol; 1991; 80 Suppl 5():3-6. PubMed ID: 1776333
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived relaxing and contracting factors.
Rubanyi GM
J Cell Biochem; 1991 May; 46(1):27-36. PubMed ID: 1874796
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors.
Nolte C; Eigenthaler M; Schanzenbächer P; Walter U
J Biol Chem; 1991 Aug; 266(22):14808-12. PubMed ID: 1650367
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.
Mitchell JA; Ali F; Bailey L; Moreno L; Harrington LS
Exp Physiol; 2008 Jan; 93(1):141-7. PubMed ID: 17965142
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
[TBL] [Abstract][Full Text] [Related]
11. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
Lückhoff A; Pohl U; Mülsch A; Busse R
Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
[TBL] [Abstract][Full Text] [Related]
12. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes].
Vanhoutte PM
Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1161-6. PubMed ID: 8248687
[TBL] [Abstract][Full Text] [Related]
13. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
[TBL] [Abstract][Full Text] [Related]
15. The endothelium in acute coronary syndromes.
Noll G; Lüscher TF
Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived relaxing factors and converting enzyme inhibition.
Vanhoutte PM; Boulanger CM; Mombouli JV
Am J Cardiol; 1995 Nov; 76(15):3E-12E. PubMed ID: 7484885
[TBL] [Abstract][Full Text] [Related]
17. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells.
Warner TD
Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631
[TBL] [Abstract][Full Text] [Related]
18. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
[TBL] [Abstract][Full Text] [Related]
19. [Significance of endothelial cells for the regulation of the tone of smooth muscle--formation of an endothelial, relaxing factor].
Förstermann U
Z Kardiol; 1986 Oct; 75(10):577-83. PubMed ID: 2878541
[TBL] [Abstract][Full Text] [Related]
20. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.
Radomski MW; Palmer RM; Moncada S
Biochem Biophys Res Commun; 1987 Nov; 148(3):1482-9. PubMed ID: 2825688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
